{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T11:06:52Z","timestamp":1767611212705},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5,1]]},"DOI":"10.2146\/ajhp130132","type":"journal-article","created":{"date-parts":[[2014,4,14]],"date-time":"2014-04-14T16:50:52Z","timestamp":1397494252000},"page":"711-716","source":"Crossref","is-referenced-by-count":3,"title":["Use of argatroban and catheter-directed thrombolysis with alteplase in an oncology patient with heparin-induced thrombocytopenia with thrombosis"],"prefix":"10.1093","volume":"71","author":[{"given":"Brian","family":"Dee","sequence":"first","affiliation":[{"name":"Clinical Pharmacy Specialist\u2014Stem Cell Transplantation, Division of Pharmacy, University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey Lombardi","family":"Thomas","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Specialist\u2014Stem Cell Transplantation, Division of Pharmacy, University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Gulbis","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Specialist\u2014Stem Cell Transplantation, Division of Pharmacy, University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"2019041211002246900_b1-0710711","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin","volume":"332","author":"Warkentin","year":"1995","journal-title":"N Engl J Med"},{"key":"2019041211002246900_b2-0710711","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9343(96)00258-6","article-title":"A 14-year study of heparin induced thrombocytopenia","volume":"101","author":"Warkentin","year":"1996","journal-title":"Am J Med"},{"key":"2019041211002246900_b3-0710711","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/archinte.163.20.2518","article-title":"An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients","volume":"163","author":"Warkentin","year":"2003","journal-title":"Arch Intern Med"},{"key":"2019041211002246900_b4-0710711","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1160\/TH04-12-0825","article-title":"Clinical features of heparin-induced thrombocytopenia, including risk factors for thrombosis: a retrospective analysis of 408 patients","volume":"94","author":"Greinacher","year":"2005","journal-title":"Thromb Haemost"},{"key":"2019041211002246900_b5-0710711","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1097\/CCM.0b013e31824e1865","article-title":"Oncologic emergencies","volume":"40","author":"McCurdy","year":"2012","journal-title":"Crit Care Med"},{"key":"2019041211002246900_b6-0710711","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/01.md.0000198474.99876.f0","article-title":"The superior vena cava syndrome: clinical characteristics and evolving etiology","volume":"85","author":"Rice","year":"2006","journal-title":"Medicine"},{"key":"2019041211002246900_b7-0710711","doi-asserted-by":"crossref","first-page":"e495S","DOI":"10.1378\/chest.11-2303","article-title":"Treatment and prevention of heparin induced thrombocytopenia: anti-thrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidenced-based clinical practice guidelines","volume":"141","author":"Linkins","year":"2012","journal-title":"Chest"},{"key":"2019041211002246900_b8-0710711","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1592\/phco.28.9.1115","article-title":"Safety, efficacy, and dosing requirements of bivalirudin in patients with heparin-induced thrombocytopenia","volume":"28","author":"Kiser","year":"2008","journal-title":"Pharmacotherapy"},{"key":"2019041211002246900_b9-0710711","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1592\/phco.26.4.461","article-title":"Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia","volume":"26","author":"Dang","year":"2006","journal-title":"Pharmacotherapy"},{"key":"2019041211002246900_b10-0710711","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/1076029609347900","article-title":"Fondaparinux for the treatment of acute heparin-induced thrombocytopenia: a single-center experience","volume":"16","author":"Grouzi","year":"2010","journal-title":"Clin Appl Thromb Hemost"},{"key":"2019041211002246900_b11-0710711","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1160\/TH07-04-0252","article-title":"Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia","volume":"99","author":"Lobo","year":"2008","journal-title":"Thromb Haemost"},{"key":"2019041211002246900_b12-0710711","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/1531003510378756","article-title":"Catheter-directed thrombectomy and thrombolysis for symptomatic lower-extremity deep vein thrombosis: review of current interventional strategies","volume":"22","author":"Lin","year":"2010","journal-title":"Perspect Vasc Surg Endovasc Ther"},{"key":"2019041211002246900_b13-0710711","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ejrad.2008.04.015","article-title":"Percutaneous mechanical thrombectomy combined with catheter-directed thrombolysis in the treatment of symptomatic lower extremity deep venous thrombosis","volume":"71","author":"Shi","year":"2009","journal-title":"Eur J Radiol"},{"key":"2019041211002246900_b14-0710711","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.amjsurg.2006.08.045","article-title":"Catheter-direct thrombolysis versus pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis","volume":"192","author":"Lin","year":"2006","journal-title":"Am J Surg"},{"key":"2019041211002246900_b15-0710711","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1051-0443(07)61418-3","article-title":"Alteplase as an alternative to urokinase: Advisory Panel on Catheter-Directed Thrombolytic Therapy","volume":"11","author":"Semba","year":"2000","journal-title":"J Vasc Interv Radiol"},{"key":"2019041211002246900_b16-0710711","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/153857440503900309","article-title":"Endoluminal recanalization in a patient with phlegmasia cerulea dolens using a multimodality approach: a case report","volume":"39","author":"Lin","year":"2005","journal-title":"Vasc Endovasc Surg"},{"key":"2019041211002246900_b17-0710711","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/ccd.21304","article-title":"Catheter-directed thrombolysis of acute lower extremity arterial thrombosis in a patient with heparin-induced thrombocytopenia","volume":"70","author":"Turba","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"2019041211002246900_b18-0710711","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ajh.21367","article-title":"Argatroban and catheter-directed thrombolysis with alteplase for limb- and graft-threatening thromboses in a patient with a history of HIT","volume":"84","author":"Maldonado","year":"2009","journal-title":"Am J Hematol"},{"key":"2019041211002246900_b19-0710711","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/bmt.2010.106","article-title":"Low risk of symptomatic venous thromboembolic events during growth factor administration for PBSC mobilization","volume":"46","author":"Naina","year":"2011","journal-title":"Bone Marrow Transplant"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/71\/9\/711\/28372508\/ajhp0711.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T20:47:30Z","timestamp":1555102050000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/71\/9\/711\/5111209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,1]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,5,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp130132","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,5,1]]},"published":{"date-parts":[[2014,5,1]]}}}